Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Piramal Pharma Limited ( (IN:PPLPHARMA) ) is now available.
Piramal Pharma Limited’s board has expanded its senior management team by designating four officials as Senior Management Personnel, including the Chief Quality Officer, President – Mergers and Acquisitions, General Counsel and Chief Human Resource Officer, reflecting a formal strengthening of leadership across quality, strategic transactions, legal and human resources functions. Separately, the board has accepted the resignation of Company Secretary and Compliance Officer Tanya Sanish, effective 20 February 2026, and has appointed Pratibha Mishra as Interim Company Secretary and Compliance Officer from 21 February 2026, ensuring continuity in corporate governance and regulatory compliance responsibilities.
More about Piramal Pharma Limited
Piramal Pharma Limited is an India-based pharmaceutical company engaged in the development, manufacturing and distribution of pharma products and services. The company operates across multiple segments of the healthcare and life sciences industry and is listed on both BSE and the National Stock Exchange of India under the symbol PPLPHARMA.
Average Trading Volume: 222,676
Technical Sentiment Signal: Sell
Current Market Cap: 201.2B INR
For detailed information about PPLPHARMA stock, go to TipRanks’ Stock Analysis page.